What is the address of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

The registered office of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE is located at Leieriggestraat 18, 9051 Gent.

What is the revenue of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

As a small company, Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 827,481.

Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE

Q: Is Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE still active?

Yes. According to the CBE (2 November 2026) Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE is active, legal situation “Normale toestand”, started on 3 October 2007.

Q: Is Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE registered on Peppol?

Yes, Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE is registered on the Peppol network with ID 0208:0892512836.

Q: What is the enterprise number of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

The enterprise number of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE is BE0892512836.

Q: Who are the directors of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

According to the 2025 annual accounts, the directors of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE are: DENIS MARICHAL, JOSEPHINE WITTERS.

Q: Is Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 3 October 2007; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account; 1 events from the Belgian Official Gazette processed.

Dossier Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE, printed on 3 November 2026 from databakkes.be/en/0892512836/dr-marichal-gastro-enterologie-en-dr-witters-ophtalmologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE from Gent, company number BE0892512836, closed financial year 2025 with a result of € 546,125 after tax. For that financial year Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE recorded a gross margin of € 827,481 and equity of € 1.7 million. Compared with financial year 2024, the result moved from € 492,859 to € 546,125. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 29, 2026.

What it is worth Healthy

€ 1.7 million

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 546,125

▲ 11% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 636,196

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 664,914 paid out

More than the year’s profit went to the shareholders; reserves fell.

Debts at end 2025

Bank debt ≈ 8 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 679,156

▲ 2% vs 2024

€ 90,493 is repaid this year. At this pace the long-term loan is gone in ≈ 8 years.

Owed to suppliers

€ 524

▼ 95% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 32,263

▼ 27% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 598,494 Gross margin 2022: € 598,494 First fiscal year in the series	€ 622,217 Gross margin 2023: € 622,217 ▲ 4% vs 2022 (€ 598,494) Favourable step	€ 844,909 Gross margin 2024: € 844,909 ▲ 36% vs 2023 (€ 622,217) Favourable step	€ 827,481 Gross margin 2025: € 827,481 ▼ 2% vs 2024 (€ 844,909) Unfavourable step	▼ 2%
Profit after taxes	€ 323,216 Profit after taxes 2022: € 323,216 First fiscal year in the series	€ 328,071 Profit after taxes 2023: € 328,071 ▲ 2% vs 2022 (€ 323,216) Favourable step	€ 492,859 Profit after taxes 2024: € 492,859 ▲ 50% vs 2023 (€ 328,071) Favourable step	€ 546,125 Profit after taxes 2025: € 546,125 ▲ 11% vs 2024 (€ 492,859) Favourable step	▲ 11%
Equity	€ 1,321,960 Equity 2022: € 1,321,960 First fiscal year in the series	€ 1,487,659 Equity 2023: € 1,487,659 ▲ 13% vs 2022 (€ 1,321,960) Favourable step	€ 1,822,729 Equity 2024: € 1,822,729 ▲ 23% vs 2023 (€ 1,487,659) Favourable step	€ 1,703,940 Equity 2025: € 1,703,940 ▼ 7% vs 2024 (€ 1,822,729) Unfavourable step	▼ 7%
Total debts	€ 890,130 Total debts 2022: € 890,130 First fiscal year in the series	€ 762,059 Total debts 2023: € 762,059 ▼ 14% vs 2022 (€ 890,130) Favourable step	€ 718,419 Total debts 2024: € 718,419 ▼ 6% vs 2023 (€ 762,059) Favourable step	€ 712,020 Total debts 2025: € 712,020 ▼ 1% vs 2024 (€ 718,419) Favourable step	▼ 1%
Cash	€ 188,578 Cash 2022: € 188,578 First fiscal year in the series	€ 258,995 Cash 2023: € 258,995 ▲ 37% vs 2022 (€ 188,578) Favourable step	€ 633,211 Cash 2024: € 633,211 ▲ 144% vs 2023 (€ 258,995) Favourable step	€ 636,196 Cash 2025: € 636,196 Unchanged (€ 633,211) Favourable step
Land & buildings	€ 1,336,847 Land & buildings 2022: € 1,336,847 First fiscal year in the series	€ 1,266,026 Land & buildings 2023: € 1,266,026 ▼ 5% vs 2022 (€ 1,336,847) Unchanged	€ 1,432,573 Land & buildings 2024: € 1,432,573 ▲ 13% vs 2023 (€ 1,266,026) Unchanged	€ 1,373,935 Land & buildings 2025: € 1,373,935 ▼ 4% vs 2024 (€ 1,432,573) Unchanged	▼ 4%
Retained profit	€ 1,303,360 Retained profit 2022: € 1,303,360 First fiscal year in the series	€ 1,469,059 Retained profit 2023: € 1,469,059 ▲ 13% vs 2022 (€ 1,303,360) Favourable step	€ 1,804,129 Retained profit 2024: € 1,804,129 ▲ 23% vs 2023 (€ 1,469,059) Favourable step	€ 1,685,340 Retained profit 2025: € 1,685,340 ▼ 7% vs 2024 (€ 1,804,129) Unfavourable step	▼ 7%
Dividend	€ 236,550 Dividend 2022: € 236,550 First fiscal year in the series	€ 162,373 Dividend 2023: € 162,373 ▼ 31% vs 2022 (€ 236,550) Unchanged	€ 157,789 Dividend 2024: € 157,789 ▼ 3% vs 2023 (€ 162,373) Unchanged	€ 664,914 Dividend 2025: € 664,914 ▲ € 507,125 vs 2024 (€ 157,789) Unchanged	▲ € 507,125
Bank debt	€ 793,855 Bank debt 2022: € 793,855 First fiscal year in the series	€ 746,045 Bank debt 2023: € 746,045 ▼ 6% vs 2022 (€ 793,855) Favourable step	€ 663,382 Bank debt 2024: € 663,382 ▼ 11% vs 2023 (€ 746,045) Favourable step	€ 679,156 Bank debt 2025: € 679,156 ▲ 2% vs 2024 (€ 663,382) Unfavourable step	▲ 2%
Balance sheet total	€ 2,212,090 Balance sheet total 2022: € 2,212,090 First fiscal year in the series	€ 2,249,718 Balance sheet total 2023: € 2,249,718 ▲ 2% vs 2022 (€ 2,212,090) Unchanged	€ 2,541,148 Balance sheet total 2024: € 2,541,148 ▲ 13% vs 2023 (€ 2,249,718) Unchanged	€ 2,415,960 Balance sheet total 2025: € 2,415,960 ▼ 5% vs 2024 (€ 2,541,148) Unchanged	▼ 5%

Key figures of Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

What happened at Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 29, 2026 New annual accounts for financial year 2025: profit of € 546,125 (▲ 11% vs 2024). filed late Source: NBB ↗
Oct 11, 2007 Incorporation, published in the Gazette. Source: Staatsblad ↗
Sep 25, 2007 New establishment in Gent. KBO

In short

From € 323,216 profit in 2022 to € 546,125 profit in 2025.

Paid € 780,106 in corporate taxes since 2022.

Best year ever: 2025, with € 546,125 profit.

Paid out € 1.2 million in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DENIS MARICHAL JOSEPHINE WITTERS

Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE

Behind Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE are DENIS MARICHAL and JOSEPHINE WITTERS.

Directors

According to the 2025 annual accounts

DENIS MARICHAL

Director

JOSEPHINE WITTERS

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Leieriggestraat 18

9051 Gent

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Shareholders according to the Official Gazette deeds

Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.

Incorporation

11 October 2007 Source: Deed ↗

MARICHAL Denis Elie Etienne Dick(oprichter) 100%

Details

Company number: 0892.512.836
VAT number: BE 0892.512.836
Registered office: Leieriggestraat 18, 9051 Gent
Names & denominations: Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 3 October 2007
Peppol: Active · Active since 5 Jan 2026
Contact: 0032497038950

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE

Financials

What happened to Dr. MARICHAL, GASTRO-ENTEROLOGIE en Dr. WITTERS, OPHTALMOLOGIE?

Management

Directors

Establishments

Establishment units

Shareholders according to the Official Gazette deeds

Details

Frequently asked questions